The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage
Abstract Background Cardiac involvement in Fabry Disease (FD) occurs prior to left ventricular hypertrophy (LVH) and is characterized by low myocardial native T1 with storage reflected by cardiovascular magnetic resonance (CMR) and ECG changes. Objectives We hypothesize that a pre-storage myocardial...
Saved in:
Published in | European heart journal Vol. 41; no. Supplement_2 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.11.2020
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Background
Cardiac involvement in Fabry Disease (FD) occurs prior to left ventricular hypertrophy (LVH) and is characterized by low myocardial native T1 with storage reflected by cardiovascular magnetic resonance (CMR) and ECG changes.
Objectives
We hypothesize that a pre-storage myocardial phenotype might occur even earlier, prior to T1 lowering.
Methods
FD patients and age, sex and heart rate matched healthy controls underwent same-day ECG with advanced analysis and multiparametric CMR (cines, global longitudinal strain [GLS], T1 and T2 mapping, stress perfusion [myocardial blood flow, MBF] and late gadolinium enhancement [LGE]).
Results
114 Fabry patients (46±13 years, 61% female) and 76 controls (49±15 years, 50% female) were included. In pre-LVH FD (n=72, 63%), a low T1 (n=32/72, 44%) was associated with a constellation of ECG and functional abnormalities compared to normal T1 FD patients and controls. However, pre-LVH FD with normal T1 (n=40/72, 56%) also had abnormalities compared to controls: reduced GLS (−18±2 vs −20±2%, P<0.001), microvascular changes (lower MBF 2.5±0.7 vs 3.0±0.8mL/g/min, P=0.028), subtle T2 elevation (50±4 vs 48±2ms, p=0.027) and limited LGE (%LGE 0.3±1.1 vs 0%, P=0.004). ECG abnormalities included shorter P wave duration (88±12 vs 94±15ms, P=0.010) and T wave peak time (Tonset–Tpeak; 104±28 vs 115±20ms, P=0.015), resulting in a more symmetric T wave with lower T wave time ratio (Tonset–Tpeak)/(Tpeak–Tend) (1.5±0.4 vs 1.8±0.4, P<0.001) compared to controls.
Conclusions
FD has a measurable myocardial phenotype pre-LVH and pre-detectable myocyte storage with microvascular dysfunction, subtly impaired GLS and altered atrial depolarization and ventricular repolarization intervals.
Proposed stages of cardiac involvement
Funding Acknowledgement
Type of funding source: None |
---|---|
AbstractList | Abstract
Background
Cardiac involvement in Fabry Disease (FD) occurs prior to left ventricular hypertrophy (LVH) and is characterized by low myocardial native T1 with storage reflected by cardiovascular magnetic resonance (CMR) and ECG changes.
Objectives
We hypothesize that a pre-storage myocardial phenotype might occur even earlier, prior to T1 lowering.
Methods
FD patients and age, sex and heart rate matched healthy controls underwent same-day ECG with advanced analysis and multiparametric CMR (cines, global longitudinal strain [GLS], T1 and T2 mapping, stress perfusion [myocardial blood flow, MBF] and late gadolinium enhancement [LGE]).
Results
114 Fabry patients (46±13 years, 61% female) and 76 controls (49±15 years, 50% female) were included. In pre-LVH FD (n=72, 63%), a low T1 (n=32/72, 44%) was associated with a constellation of ECG and functional abnormalities compared to normal T1 FD patients and controls. However, pre-LVH FD with normal T1 (n=40/72, 56%) also had abnormalities compared to controls: reduced GLS (−18±2 vs −20±2%, P<0.001), microvascular changes (lower MBF 2.5±0.7 vs 3.0±0.8mL/g/min, P=0.028), subtle T2 elevation (50±4 vs 48±2ms, p=0.027) and limited LGE (%LGE 0.3±1.1 vs 0%, P=0.004). ECG abnormalities included shorter P wave duration (88±12 vs 94±15ms, P=0.010) and T wave peak time (Tonset–Tpeak; 104±28 vs 115±20ms, P=0.015), resulting in a more symmetric T wave with lower T wave time ratio (Tonset–Tpeak)/(Tpeak–Tend) (1.5±0.4 vs 1.8±0.4, P<0.001) compared to controls.
Conclusions
FD has a measurable myocardial phenotype pre-LVH and pre-detectable myocyte storage with microvascular dysfunction, subtly impaired GLS and altered atrial depolarization and ventricular repolarization intervals.
Proposed stages of cardiac involvement
Funding Acknowledgement
Type of funding source: None |
Author | Nordin, S Seraphim, A Bicho Augusto, J.A Johner, N Knott, K Moon, J Ramaswami, U Kozor, R Shah, D Lau, C Hughes, D Steeds, R Alfarih, M Vijapurapu, R Namdar, M |
Author_xml | – sequence: 1 givenname: J.A surname: Bicho Augusto fullname: Bicho Augusto, J.A organization: University College London, London, United Kingdom – sequence: 2 givenname: N surname: Johner fullname: Johner, N organization: Geneva University Hospitals, Cardiology Division, Geneva, Switzerland – sequence: 3 givenname: D surname: Shah fullname: Shah, D organization: Geneva University Hospitals, Cardiology Division, Geneva, Switzerland – sequence: 4 givenname: S surname: Nordin fullname: Nordin, S organization: Barts Health NHS Trust, London, United Kingdom – sequence: 5 givenname: K surname: Knott fullname: Knott, K organization: University College London, London, United Kingdom – sequence: 6 givenname: C surname: Lau fullname: Lau, C organization: Barts Health NHS Trust, London, United Kingdom – sequence: 7 givenname: M surname: Alfarih fullname: Alfarih, M organization: University College London, London, United Kingdom – sequence: 8 givenname: A surname: Seraphim fullname: Seraphim, A organization: University College London, London, United Kingdom – sequence: 9 givenname: R surname: Vijapurapu fullname: Vijapurapu, R organization: Queen Elizabeth Hospital Birmingham, Department of Cardiology, Birmingham, United Kingdom – sequence: 10 givenname: U surname: Ramaswami fullname: Ramaswami, U organization: Royal Free Hospital, lysosomal storage disorders unit, London, United Kingdom – sequence: 11 givenname: R surname: Steeds fullname: Steeds, R organization: Queen Elizabeth Hospital Birmingham, Department of Cardiology, Birmingham, United Kingdom – sequence: 12 givenname: R surname: Kozor fullname: Kozor, R organization: University of Sydney, Sydney Medical School, Sydney, Australia – sequence: 13 givenname: D surname: Hughes fullname: Hughes, D organization: Royal Free Hospital, lysosomal storage disorders unit, London, United Kingdom – sequence: 14 givenname: J surname: Moon fullname: Moon, J organization: Barts Health NHS Trust, London, United Kingdom – sequence: 15 givenname: M surname: Namdar fullname: Namdar, M organization: Geneva University Hospitals, Cardiology Division, Geneva, Switzerland |
BookMark | eNot0E1qwzAQBWBRUmiS9gJd6QJO9WPJ1rKEpi0EunGhOzOSRrVDYhnJG9--SZrNPJgHb_GtyGKIAxLyzNmGMyNfsDu4_nwBTKk3gktxR5ZcCVEYXaoFWTJuVKF1_fNAVjkfGGO15npJmqZDepqjg-R7ONKxwyFO84g0BroDm2bq-4yQkY4Ji-7cpCnFsZspDP768zihm8AekeYpJvjFR3If4Jjx6ZZr8r17a7Yfxf7r_XP7ui8cF0oUEHxgFat4FayxSgCXUtQsWCsRUXlfS12VYBxwXmJpHBOVL6W2lRbMaiXXRPzvuhRzThjaMfUnSHPLWXtxaa8u7c2lvbjIPxm7W8o |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1093/ehjci/ehaa946.2132 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1522-9645 |
ExternalDocumentID | 10_1093_ehjci_ehaa946_2132 |
GroupedDBID | --- -E4 .2P .I3 .XZ .ZR 08P 0R~ 18M 1TH 29G 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAJKP AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAUQX AAVAP AAYXX ABEUO ABIXL ABKDP ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABWST ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AIAGR AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCGUY BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CITATION CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M41 M49 MHKGH ML0 N9A NGC NOMLY NOYVH NU- O9- OAUYM OAWHX OB3 OCZFY ODMLO OGROG OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX ROZ RUSNO RW1 RXO SEL TCURE TEORI TJX W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 |
ID | FETCH-LOGICAL-c1252-afdf070717fb9b52a133280fbb3eee5dd83674a9ca114e49c027d436b7620b653 |
ISSN | 0195-668X |
IngestDate | Thu Sep 12 18:58:02 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1252-afdf070717fb9b52a133280fbb3eee5dd83674a9ca114e49c027d436b7620b653 |
OpenAccessLink | https://archive-ouverte.unige.ch/unige:148838/ATTACHMENT01 |
ParticipantIDs | crossref_primary_10_1093_ehjci_ehaa946_2132 |
PublicationCentury | 2000 |
PublicationDate | 2020-11-01 |
PublicationDateYYYYMMDD | 2020-11-01 |
PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | European heart journal |
PublicationYear | 2020 |
SSID | ssj0008616 |
Score | 2.3914447 |
Snippet | Abstract
Background
Cardiac involvement in Fabry Disease (FD) occurs prior to left ventricular hypertrophy (LVH) and is characterized by low myocardial native... |
SourceID | crossref |
SourceType | Aggregation Database |
Title | The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFA86QbyIn_hNDt5GtzZN0vYoogxhO22wW0na1Cq4Se0O-tf7kmZtJxOcl1K68Wj7fk3e-70vhG496VKaeKEjM5eCg5LCGUsz-OIjxoSbUao03zEc8cGEPk3ZtIngm-qSUvaSr7V1Jf_RKlwDveoq2Q00WwuFC3AO-oUjaBiOf9bx2yfsRoUp_9DpWnPDqYIF-Chk8bmMv-hWAE4OvxRlMYcXu2wP4KRKBxFM-ZROkxSrmUE1Va_HXpfd9j0ZXh2Wzu7d4nnxUVbxm14Nh6e6kqYJ9eQiX0kxHoHf-9KiXy33AI6mV3MPlo6MmMO5GQ4Mu4ldQsG9jXjVJHK5xlKvhSUzr9SQnzFZu4pXHa5U_poYveZCRJT3iGeZ0JWm2T82szrFsAqu-7GRElsZsZaxjXZIAEjUleHTJh8o5GZObv1ItsIKZPSNjH77PlpWTMscGR-gfetH4LsKFIdoS82O0O7QZkocozFgAzfYwDU28DzDBhvYYgP_wAYGbOBVbGCLjRM0eXwY3w8cO0HDScBwJY7I0kz3c_KCTEaSEeH5PgndTEpfKcXSNPR5QEWUCHCLFY0SlwQp9bmELdKVnPmnqDObz9QZwmnAqOS-IAl8wKFHJXEFpwIM2JCzSIpz1F2-kfi9apQS_66Di43-fYn2GvRdoU5ZLNQ12IKlvDE6_AbiSWIh |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+myocardial+phenotype+of+Fabry+disease+pre-hypertrophy+and+pre-detectable+storage&rft.jtitle=European+heart+journal&rft.au=Bicho+Augusto%2C+J.A&rft.au=Johner%2C+N&rft.au=Shah%2C+D&rft.au=Nordin%2C+S&rft.date=2020-11-01&rft.issn=0195-668X&rft.eissn=1522-9645&rft.volume=41&rft.issue=Supplement_2&rft_id=info:doi/10.1093%2Fehjci%2Fehaa946.2132&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_ehjci_ehaa946_2132 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon |